US Patent 8981084 Oxadiazole HDAC inhibitors
Patent 8981084 was granted and assigned to Tempero Pharmaceuticals, Inc. on March, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+58 characters)
Article
Patent abstract
Disclosed are compounds having the formula:
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Darby Schmidt0
Erkan Baloglu0
Mercedes Lobera0
Shomir Ghosh0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08981084 Oxadiazole HDAC inhibitors US Patent 8981084 Oxadiazole HDAC inhibitors
Infobox
Patent Number
089810840
Patent Number
89810840
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
089810840
Date of Patent
March 17, 2015
0Patent Application Number
135220700
Date Filed
January 13, 2011
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08981084 Oxadiazole HDAC inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08981084
Date of patent
March 17, 2015
Patent application number
13522070
Date Filed
January 13, 2011
Patent primary examiner
Find more entities like US Patent 8981084 Oxadiazole HDAC inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
